surmount-1 tirzepatide obesity nejm 2022 weight loss percent vs Semaglutide: Winner? π π 72-Week Data: Tirzepatide: ~20% body weight loss Semaglutide: ~14% body weight loss π‘ Tirzepatide shows greater weight & HbA1c reduction, but cost, side NEJM trial data on orforglipron
Pay in 4 interest-free payments of $6.98 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 5 - Aug 10
00656-2/asset/4f1ded76-ee8b-43be-8831-191c2d3358e3/main.assets/gr3_lrg.jpg)


























